CA9 and cancer: Under hypoxic conditions, HIF-1α is stabilized and translocates to the nucleus, where it dimerizes with HIF-1β and activates the expression of a broad range of target genes including glucose transporter 1 (Glut1) and carbonic anhydrase IX (CAIX), facilitating tumorigenesis and cancer progression [6–8].